The Food and Drug Administration (FDA) has approved the sale of Atripla, a once-a-day pills that contains three FDA-approved drugs that can be taken in a single dose.

The "cocktail" was approved for sale by the FDA on Wednesday and will be made available within seven working days. The new drug is expected to be a big help to HIV-positive patients

A drug combination developed by a Silicon Valley company, Gilead Sciences, promise combating HIV in a small group of monkeys, The Associated Press reports.

If larger tests show the drugs work, they could be given to people at highest risk of HIV - from gay men in American cities to women in Africa who catch the virus from their partners

Scientists are hopeful that a cocktail of two drugs already used to treat HIV infection may prevent the spread of the virus.

Thomas Folks, head of the HIV research lab at the U.S. Center for Disease Control and Prevention says, "This is the first thing I've seen that I think could have a prevention impact

An injection of two drugs normally used to treat HIV patients completely protected monkeys from becoming infected with the AIDS virus, researchers said yesterday. While it is too early to tell whether people can pop a pill and escape infection, the study provides the strongest evidence yet that it might be possible.

Dr. Walid Heneine of the Centers for Disease Control and Prevention studied rhesus monkeys that were injected with a version of Truvada and Emtriva. For 14 days, the monkeys were then exposed to a combined human-monkey AIDS virus